Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes.

Acta diabetologica - 1 Jun 2013

Mancera-Romero J, Sánchez-Chaparro M A, Rioja J, Ariza M J, Olivecrona G, González-Santos P, Valdivielso P

Abstract excerpt

An earlier study showed that fasting and postprandial concentrations of apolipoprotein B48 were raised in patients with type 2 diabetes (DM2) and peripheral arterial disease (PAD) as compared with persons without DM2 or persons with DM2 but not PAD. The aim of this study was to confirm the association of PAD and B48 in a larger group of patients with DM2 and the relation of B48 with the preheparin lipoprotein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins E
Share to Diabetic Angiopathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fasting

Share to Hypoglycemic Agents

Share to Hypolipidemic Agents

Share to Insulin

Share to Lipoprotein Lipase

Share to Peripheral Arterial Disease

Source

Identifiers

PMID: 23053881
DOI: 10.1007/s00592-012-0434-x

Genes

LPL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes.PMID 23053881Read ↗

Large and small peripheral arterial disease in persons with type 2 diabetesSemantic proximity Read ↗

Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.Semantic proximity Read ↗

Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.Semantic proximity Read ↗

The performance of lipid profiles and ratios as a predictor of arterial stiffness measured by brachial-ankle pulse wave velocity in type 2 diabetic patientsSemantic proximity Read ↗

Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus.Semantic proximity Read ↗

LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes.Semantic proximity Read ↗

Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease.Semantic proximity Read ↗

Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus.Semantic proximity Read ↗

Ankle-brachial index and peripheral arterial disease.Semantic proximity Read ↗

Lipids, lipoproteins and apolipoprotein (a) isoforms in type 2 diabetic patients.Semantic proximity Read ↗

Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus.Semantic proximity Read ↗

Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.